Differentiation therapy using low‐dose venetoclax in a variant acute promyelocytic leukaemia carrying <scp> <i>ZBTB16‐RARA</i> </scp>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differentiation therapy using low‐dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16‐RARA

Published:2022-09-28 Issue:5 Volume:199 Page:768-771
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Li He¹^ORCID,Xiang Xinrong¹²^ORCID,Ding Hong¹,Yu Jiang³,Xu Juan¹,Yuan Ying⁴,Wu Yu¹^ORCID

Affiliation:

1. Department of Hematology and Hematology Research Institute West China Hospital, Sichuan University Chengdu People's Republic of China

2. State Key Laboratory of Biotherapy and Cancer Center West China Hospital, Sichuan University Chengdu People's Republic of China

3. Department of Laboratory Medicine West China Hospital, Sichuan University Chengdu People's Republic of China

4. Department of Hematology Guangyuan Central Hospital Sichuan People's Republic of China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18476

Reference10 articles.

1. PLZF-RARα, NPM1-RARα, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review

2. RAR -PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia

3. Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid

4. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

5. Venetoclax for arsenic‐resistant acute promyelocytic leukaemia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Round Promyelocyte Cells with Round Nuclei: Clues to the Diagnosis of ZBTB16-RARA Acute Promyelocytic Leukemia;Turkish Journal of Hematology;2023-12-28

2. Venetoclax overcomes resistance to all‐trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion;Molecular Carcinogenesis;2023-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3